Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ann Marie Flusche"'
Autor:
Ilgen Mender, Silvia Siteni, Summer Barron, Ann Marie Flusche, Naoto Kubota, Chunhua Yu, Crystal Cornelius, Enzo Tedone, Mazvita Maziveyi, Anthony Grichuk, Niranjan Venkateswaran, Maralice Conacci-Sorrell, Yujin Hoshida, Rui Kang, Daolin Tang, Sergei Gryaznov, Jerry W. Shay
Publikováno v:
Molecular Cancer Therapeutics. :OF1-OF14
A select group of patients with hepatocellular carcinomas (HCC) benefit from surgical, radiologic, and systemic therapies that include a combination of anti-angiogenic and immune-checkpoint inhibitors. However, because HCC is generally asymptomatic i
Autor:
Jerry W. Shay, Sergei Gryaznov, Daolin Tang, Rui Kang, Yujin Hoshida, Maralice Conacci-Sorrell, Niranjan Venkateswaran, Anthony Grichuk, Mazvita Maziveyi, Enzo Tedone, Crystal Cornelius, Chunhua Yu, Naoto Kubota, Ann Marie Flusche, Summer Barron, Silvia Siteni, Ilgen Mender
Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2a68e235cf683d0da0befbfe3a97184
https://doi.org/10.1158/1535-7163.22932201
https://doi.org/10.1158/1535-7163.22932201
Autor:
Jerry W. Shay, Sergei Gryaznov, Daolin Tang, Rui Kang, Yujin Hoshida, Maralice Conacci-Sorrell, Niranjan Venkateswaran, Anthony Grichuk, Mazvita Maziveyi, Enzo Tedone, Crystal Cornelius, Chunhua Yu, Naoto Kubota, Ann Marie Flusche, Summer Barron, Silvia Siteni, Ilgen Mender
Supplementary Table 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f0e7b5983b24d663b2a32280bdb32fa
https://doi.org/10.1158/1535-7163.22932195
https://doi.org/10.1158/1535-7163.22932195
Autor:
Jerry W. Shay, Sergei Gryaznov, Daolin Tang, Rui Kang, Yujin Hoshida, Maralice Conacci-Sorrell, Niranjan Venkateswaran, Anthony Grichuk, Mazvita Maziveyi, Enzo Tedone, Crystal Cornelius, Chunhua Yu, Naoto Kubota, Ann Marie Flusche, Summer Barron, Silvia Siteni, Ilgen Mender
Supplementary Data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11c6bb95fa2e7d5db2e4baf3eea41498
https://doi.org/10.1158/1535-7163.22932198.v1
https://doi.org/10.1158/1535-7163.22932198.v1
Publikováno v:
Cancer Research. 83:4143-4143
Hepatocellular carcinoma (HCC) is the most common primary malignant tumor of the liver and is the third leading cause of cancer-related deaths. In recent years, immune checkpoint inhibitors (ICIs) have improved treatment of solid tumors including HCC